IPO Premiums
IPO calendar
SMListed

Speciality Medicines Limited

Bookbuilding IPO · BSE

Price band
₹117 - ₹124
Lot size
1,000 shares
Issue amount
₹29.14 cr
Total subscription
2.33×
Current price₹153
Listing price ₹124
Watch live price ↗
Opens
20 Mar 2026
Closes
24 Mar 2026
Allotment
25 Mar 2026
Listing
30 Mar 2026

Offer at a glance

Issue overview

Issue size
23,50,000 shares
Face value
₹10 per share
Minimum investment
₹1,17,000
Fresh issue
₹29.14 cr
Offer for sale
₹0 cr
Registrar
Skyline Financial Services Private Limited
Listing exchange
BSE
Maximum investment
₹1,24,000
Issue type
Bookbuilding IPO
Shares before issue
64,35,796
Shares after issue
87,85,796

Lot sizes

CategoryLotsSharesAmount
RETAIL22,000₹2,48,000
sHNI33,000₹3,72,000
bHNI99,000₹11,16,000

Share reservation

QIB0.89%
HNI46.34%
RETAIL46.38%
Market Maker6.38%

Subscription & GMP

Subscription by category

Total subscribed2.33×

Reported 24 Mar 2026

QIB96.24×
NIB2.01×
RETAIL0.85×
HNIs(10L+)2.7×
HNIs(2-10L)0.64×

GMP history

00.5124 Mar: ₹0
24 Mar₹024 Mar

Day-wise demand

20 Mar1.93×
23 Mar1.01×
24 Mar2.33×

Application-wise demand

CategoryReserved applicationsApplied applications
QIB02
NIB0222
RETAIL545461
HNIs(10L +)242167
HNIs (2-10L)12155

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs0.2625.06
FIIs025.06
RETAIL13.5211.43
NIB13.527.21
HNIs 2+4.52.86
HNIs 10+924.34

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profitIn Crores
0204060Mar-24 · Revenue: 27.66Mar-24 · Profit after tax: 2.93Mar-24Mar-25 · Revenue: 58.54Mar-25 · Profit after tax: 8.61Mar-25Oct-25 · Revenue: 36.93Oct-25 · Profit after tax: 6.06Oct-25
RevenueProfit after tax

Key performance indicators

MetricOct-25Mar-25Mar-24Mar-23
EPS9.4114.17.074.74
ROE0000
ROCE16.8633.3936.950.22
RONW16.6128.319.4728.6
PRE IPO(PE)09.2700
POST IPO(PE)10.49000

Values and labels as reported in the issue data.

Peer comparison

CompanyP/E(X)CMP* (₹)Face value (₹)NAV/Share (₹)RONW(%)EPS (Basic) (₹)
Speciality Medicines Limited9.27010.0047.2628.4214.10
Remus Pharmaceuticals Limited10.41010.00434.2515.0265.21
Trident Lifeline Limited27.00010.0056.0518.2310.22
Mono Pharmacare Limited7.49010.0017.669.901.75

Company information

Company profile

Speciality Medicines Limited was incorporated in 2021 and focuses on marketing and distributing speciality pharmaceutical medicines, including expensive oral and injectable drugs used to treat serious and long-term health conditions in both Indian and international markets. The company offers many types of finished pharmaceutical products in different forms such as tablets, capsules, creams, syrups, eye drops, gels, injections, inhalers, nasal sprays, ointments, sachets, and suspensions. It operates through two main models: contract manufacturing of finished medicines for international markets and marketing and distribution of speciality medicines sourced from other manufacturers. The company has expanded globally with products registered or under registration in countries like Jordan, Ethiopia, Uganda, Peru, and Namibia, and its distribution network covers more than 20 states in India and over 35 countries worldwide. As of March 31, 2025, one product was registered overseas and 60 products were under registration in five countries, contributing to revenue, and as of August 31, 2025, the company had 18 permanent employees working in different departments.

Strengths

  • Wide Global Presence: The company operates in India as well as several international markets, helping it build a diversified revenue base and reduce dependence on a single region.
  • Strong Customer Relationships: By focusing on customer needs, timely delivery, and consistent product quality, the company has developed long-term relationships and receives repeat orders from its clients.
  • Reliable Quality Standards: The company follows strict quality control practices supported by ISO 9001:2015 certification and trusted third-party manufacturing facilities, ensuring consistent product quality and on-time delivery.

Risk factors

  • Dependence on Third-Party Suppliers: The company relies on external suppliers for sourcing products. Any disruption, delay, or price fluctuations from these suppliers may affect product availability, pricing, and overall operations.
  • Strict Quality Compliance Requirements: The company’s products must meet specific customer specifications and quality standards. Any failure to meet these requirements may result in product recalls, order cancellations, or warranty claims.
  • Limited In-House R&D Capability: The company currently does not have a well-established in-house R&D team. Delays in developing this capability may impact product innovation and future growth opportunities.

Promoters

Parth B Goyani

Goyani Sumit Babubhai

Registrar & documents

Lead manager

Unicon Capital Services Private Limited

Registered office

913, One World West, S. No. 396, FP 119, Village- Vejalpur, Ahmadabad City, Ahmedabad, Gujarat, India, Ahmedabad, Gujarat, 380051

+91 22 4604 5344

[email protected]Company website ↗

Frequently Asked Questions

What is Speciality Medicines IPO GMP today?

Currently, Speciality Medicines IPO Grey Market Premium (GMP) is trading around ₹0 or awaiting active buyer-seller quotes in the grey market. The issue price is set at ₹124. Track daily updates on IPO Premiums as bidding numbers unfold.

What is the lot size and minimum investment for Speciality Medicines IPO?

The minimum bid lot size for Speciality Medicines IPO is 1,000 shares. At the cut-off price of ₹124 per share, retail investors need a minimum application amount of ₹1,24,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will Speciality Medicines IPO allotment status be announced?

The allotment status for Speciality Medicines IPO is scheduled to be finalized on 25 Mar 2026. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Skyline Financial Services Private Limited's official portal or via BSE/NSE allotment portals.

How can I check Speciality Medicines IPO allotment status online by PAN?

To check Speciality Medicines IPO allotment status: 1) Visit the registrar portal (Skyline Financial Services Private Limited) or the BSE IPO allotment page. 2) Select 'Speciality Medicines Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.